Abstract
Introduction
Q fever is an ubiquitous zoonosis caused by Coxiella burnetii. Its tropism for the uterus is a potential source of obstetric complications.
Materials and methods
We describe the obstetric consequences of Q fever diagnosed during pregnancy from a series of cases. When an antenatal diagnosis was made, antibiotic therapy with roxithromycin (Rulid®) was started until delivery.
Results
Between 2007 and 2012, 30 patients were treated for Q fever diagnosed during pregnancy, i.e. 1.9 cases per 1000 people. The most common reasons for performing serology was intrauterine growth retardation, preterm labor and oligoamnios. Q fever was diagnosed as acute and chronic in 26 and 4 cases, respectively. Progression to chronic disease occurred in 8 % of acute forms of the diseases. The prevalence of obstetric complications was 66 %, including 10 % foetal deaths, 31 % preterm delivery and 27 % low birthweight <10th percentile. The obstetric complication rate amongst the 22 patients treated with ante partum macrolides was 60, 30 % of which involved prematurity and 33 % involved low growth. No cases of foetal death were found on treatment and no congenital malformation and placental or neonatal injury was found. No case of disease reactivation was diagnosed in the eight patients who became pregnant again.
Conclusion
Q fever during pregnancy is responsible for severe obstetric complications. It must be diagnosed early and its clinical forms known in order to start appropriate antibiotic therapy.
Similar content being viewed by others
References
Tissot Dupont H, Raoult D, Brouqui P, Janbon F, Peyramond D, Weiller PJ et al (1992) Epidemiologic features and clinical presentation of acute Q fever in hospitalized patients: 323 French cases. Am J Med 93(4):427–434
Raoult D, Brouqui P (1998) Les rickettsioses. Elsevier, Paris
Bru (1983) Enquête épidémiologique de la Fièvre Q dans une commune rurale. Lyon Med 249:459–61
Raoult D, Toga B, Chaudet H, Chiche-Portiche C (1987) Rickettsial antibody in southern France: antibodies to Rickettsia conorii and Coxiella burnetii among urban, suburban and semi-rural blood donors. Trans R Soc Trop Med Hyg 81(1):80–81
Anderson AD, Kruszon-Moran D, Loftis AD, McQuillan G, Nicholson WL, Priestley RA et al (2009) Seroprevalence of Q fever in the United States, 2003–2004. Am J Trop Med Hyg 81(4):691–694
Tissot-Dupont H, Amadei M-A, Nezri M, Raoult D (2004) Wind in November, Q fever in December. Emerg Infect Dis Juill 10(7):1264–1269
Raoult D, Marrie T, Mege J (2005) Natural history and pathophysiology of Q fever. Lancet Infect Dis Avr 5(4):219–226
Maurin M, Raoult D (1999) Q fever. Clin Microbiol Rev 12(4):518–553
Anderson A, Bijlmer H, Fournier P-E, Graves S, Hartzell J, Kersh GJ et al (2013) Diagnosis and management of Q fever–United States, 2013: recommendations from CDC and the Q Fever Working Group. MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep Cent Dis Control 62:1–30
Fournier PE, Marrie TJ, Raoult D (1998) Diagnosis of Q fever. J Clin Microbiol 36(7):1823–1834
Million M, Lepidi H, Raoult D (2009) Q fever: current diagnosis and treatment options. Médecine Mal Infect Févr 39(2):82–94
Raoult D (1993) Treatment of Q fever. Antimicrob Agents Chemother 37(9):1733–1736
Carcopino X, Raoult D, Bretelle F, Boubli L, Stein A (2007) Managing Q fever during pregnancy: the benefits of long-term cotrimoxazole therapy. Clin Infect Dis Off Publ Infect Dis Soc Am 45(5):548–555
Gikas A, Kofteridis DP, Manios A, Pediaditis J, Tselentis Y (2001) Newer macrolides as empiric treatment for acute Q fever infection. Antimicrob Agents Chemother 45(12):3644–3646
Kersh GJ (2013) Antimicrobial therapies for Q fever. Expert Rev Anti Infect Ther 11(11):1207–1214
Carcopino X, Raoult D, Bretelle F, Boubli L, Stein A (2009) Q Fever during pregnancy: a cause of poor fetal and maternal outcome. Ann N Y Acad Sci 1166:79–89
Rey D, Obadia Y, Tissot-Dupont H, Raoult D (2000) Seroprevalence of antibodies to Coxiella burnetti among pregnant women in South Eastern France. Eur J Obstet Gynecol Reprod Biol 93(2):151–156
Bollani L, Strocchio L, Stronati M (2013) Congenital toxoplasmosis. Early Hum Dev 89(Supplement 4):S70–S72
Karacan M, Batukan M, Cebi Z, Berberoglugil M, Levent S, Kır M et al (2014) Screening cytomegalovirus, rubella and toxoplasma infections in pregnant women with unknown pre-pregnancy serological status. Arch Gynecol Obstet 290(6):1115–1120
Guillet M (2010) Rubéole congénitale en 2010 et vaccination. Antibiotiques 12(3):171–180
Tissot-Dupont H, Vaillant V, Rey S, Raoult D (2007) Role of sex, age, previous valve lesion, and pregnancy in the clinical expression and outcome of Q fever after a large outbreak. Clin Infect Dis Off Publ Infect Dis Soc Am 15 44(2):232–7
van der Hoek W, Meekelenkamp JCE, Leenders ACAP, Wijers N, Notermans DW, Hukkelhoven CWPM (2011) Antibodies against Coxiella burnetii and pregnancy outcome during the 2007–2008 Q fever outbreaks in The Netherlands. BMC Infect Dis 11:44
Nielsen SY, Andersen A-MN, Mølbak K, Hjøllund NH, Kantsø B, Krogfelt KA et al (2013) No excess risk of adverse pregnancy outcomes among women with serological markers of previous infection with Coxiella burnetii: evidence from the Danish National Birth Cohort. BMC Infect Dis 13:87
Munster JM, Leenders AC, Hamilton CJ, Meekelenkamp JC, Schneeberger PM, van der Hoek W et al (2013) Routine screening for Coxiella burnetii infection during pregnancy: a clustered randomised controlled trial during an outbreak, the Netherlands, 2010. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull 18(24)
Boden K, Brueckmann A, Wagner-Wiening C, Hermann B, Henning K, Junghanss T et al (2012) Maternofetal consequences of Coxiella burnetii infection in pregnancy: a case series of two outbreaks. BMC Infect Dis 12:359
Nielsen SY, Mølbak K, Henriksen TB, Krogfelt KA, Larsen CS, Villumsen S (2014) Adverse pregnancy outcomes and Coxiella burnetii antibodies in pregnant women. Denmark. Emerg Infect Dis 20(6):925–931
Angelakis E, Million M, D’Amato F, Rouli L, Richet H, Stein A et al (2013) Q fever and pregnancy: disease, prevention, and strain specificity. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol 32(3):361–368
Forland F, De Carvalho Gomes H, Nokleby H, Escriva A, Coulombier D, Giesecke J et al (2012) Applicability of evidence-based practice in public health: risk assessment on Q fever under an ongoing outbreak. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull 17(3):20060
Mylonas I (2011) Antibiotic chemotherapy during pregnancy and lactation period: aspects for consideration. Arch Gynecol Obstet 283(1):7–18
Cerar D, Karner P, Avsic-Zupanc T, Strle F (2009) Azithromycin for acute Q fever in pregnancy. Wien Klin Wochenschr 121(13–14):469–472
Munster JM, Hamilton CJCM, Leenders ACAP, Lestrade PJ (2011) Chronic Q fever during pregnancy. Ned Tijdschr Geneeskd 155:A2781
Million M, Roblot F, Carles D, D’Amato F, Protopopescu C, Carrieri MP et al (2014) Reevaluation of the risk of fetal death and malformation after Q Fever. Clin Infect Dis Off Publ Infect Dis Soc Am 59(2):256–260
Million M, Raoult D (2015) Recent advances in the study of Q fever epidemiology, diagnosis and management. J Infect 71(Suppl 1):S2–S9
Raoult D, Fenollar F, Stein A (2002) Q fever during pregnancy: diagnosis, treatment, and follow-up. Arch Intern Med 162(6):701–704
Stein A, Raoult D (1998) Q fever during pregnancy: a public health problem in southern France. Clin Infect Dis Off Publ Infect Dis Soc Am 27(3):592–596
Racult D, Stein A (1994) Q fever during pregnancy—a risk for women, fetuses, and obstetricians. N Engl J Med 330(5):371
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest with this article.
Rights and permissions
About this article
Cite this article
Coste Mazeau, P., Hantz, S., Eyraud, JL. et al. Q fever and pregnancy: experience from the Limoges Regional University Hospital. Arch Gynecol Obstet 294, 233–238 (2016). https://doi.org/10.1007/s00404-015-3958-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-015-3958-9